A Phase I, Open Lable, Multi-Center, Dose Escalation Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of PF-045148411, A TLR-9 Agonistic CPG ODN, In Patients with Advanced Solid Tumors
|Effective start/end date||9/30/08 → 9/30/09|
- PFIZER, INC.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.